Suchergebnisse - "Cogolludo, Ángel"

PubPharm (161)

1

Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension : Extensive in vitro study in rats and human

enthalten in: Vascular pharmacology | 2024

von Morales-Cano, D. | Barreira, B. | Callejo, M. | +7

2

Mitochondrial Na⁺controls oxidative phosphorylation and hypoxic redox signalling

enthalten in: bioRxiv.org | 2023

von Hernansanz-Agustín, P. | Choya-Foces, C. | Carregal-Romero, S. | +26

3

Vitamin D deficiency induces erectile dysfunction: role of superoxide

enthalten in: bioRxiv.org | 2023

von Olivencia, M. | Climent, B. | Barreira, B. | +12

4

The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Villegas-Esguevillas, M. | Cho, S. | Vera-Zambrano, A. | +12

5

Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension

enthalten in: American journal of respiratory cell and molecular biology | 2023

von Vera-Zambrano, A. | Lago-Docampo, M. | Gallego, N. | +12

CommentIn: Am J Respir Cell Mol Biol. 2023 Aug;69(2):123-125. - PMID 37201951

6

Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity

enthalten in: International journal of molecular sciences | 2023

von Olivencia, M. | Villegas-Esguevillas, M. | Sancho, M. | +6

7

Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function

enthalten in: Pharmacological research | 2023

von Vera-Zambrano, A. | Baena-Nuevo, M. | Rinné, S. | +11

8

Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature : Multilayered cross-talks in the setting of coinfections and comorbidities

enthalten in: PLoS pathogens | 2023

von Kumar, R. | Aktay-Cetin, �. | Craddock, V. | +14

9

Corrigendum : Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

enthalten in: Frontiers in pharmacology | 2023

von Morales-Cano, D. | Izquierdo-García, J. | Barreira, B. | +9

ErratumFor: Front Pharmacol. 2023 Mar 29;14:1021535. - PMID 37063275

10

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

enthalten in: Frontiers in pharmacology | 2023

von Morales-Cano, D. | Izquierdo-García, J. | Barreira, B. | +9

ErratumIn: Front Pharmacol. 2023 Jun 12;14:1228923. - PMID 37377931

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]